Kiora Pharmaceuticals Inc expected to post a loss of 86 cents a share - Earnings Preview

Kiora Pharmaceuticals

02/08/2024 18:06

* Kiora Pharmaceuticals Inc  KPRX.OQ   KPRX.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 6 (estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Kiora Pharmaceuticals
Inc is
for a loss of 86 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $27.00​, above​ its last closing price
of $4.53. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.59       -0.59      3.42      Beat    675.8
 Jan. 1 0001   -3.69       -3.77      -4.23     Missed  -12.3
 Jan. 1 0001   -3.09       -3.18      -8.01     Missed  -151.9
                                                        ​
 Jun. 30 2023  -6.63       -9.59      -7.11     Beat    25.9
 ​​Mar.        -15.41      -15.16     -9.00     Beat    40.7
 31 2023                                                
 Dec. 31 2022  -20.04      -22.14     -15.81    Beat    28.6​
 Jan. 1 0001   -33.12      -34.51     -54.30    Missed  -57.3
 Jun. 30 2022  -72.00      -72.00     -64.80    Beat    10
 This summary was machine generated August 2 at 17:06 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)